RA and SpA are clinically distinct diseases with different etiologies, both are characterized by synovial hyperplasia, elevated synovial expression of many proinflammatory cytokines including TNFα, IL-1β, and IL-6, increased angiogenesis, and eventual joint destruction [24,76,78,79]. The gene discussed is TNF; the disease is rheumatoid arthritis.